Zeria Pharmaceutical Co Ltd (4559)

Tokyo
Currency in JPY
2,211.0
+13.0(+0.59%)
Closed
4559 Scorecard
Full Analysis
High shareholder yield
Fair Value
Day's Range
2,172.02,219.0
52 wk Range
1,921.02,505.0
Key Statistics
Edit
Bid/Ask
2,201.00 / 2,218.00
Prev. Close
2,198
Open
2,202
Day's Range
2,172-2,219
52 wk Range
1,921-2,505
Volume
67K
Average Volume (3m)
57.75K
1-Year Change
8.12%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4559 Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
3,170.0
Upside
+43.37%
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 3 consecutive years
Show more

Zeria Pharmaceutical Co Ltd Company Profile

Zeria Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures, sells, imports, and exports pharmaceuticals, non-pharmaceutical products, veterinary pharmaceuticals, agricultural chemicals, industrial chemicals, and reagents in Japan and internationally. It also provides cosmetics, health foods, alcoholic beverages, soft drinks, food additives, livestock feed, hygienic goods, medical devices, health equipment, hygiene facilities and equipment, beauty appliances, and measuring and analytical equipment. The company also offers products in the gastrointestinal field, including therapeutic agents for functional dyspepsia, ulcerative colitis, Crohn’s disease, and gastritis and ulcers; zinc containing anti-ulcerants; oral bowel cleansing agents; laxatives; therapeutic agents for hypophosphatemia, and iron deficiency anemia; long-acting calcium channel blockers; oral NSAID; anti-leukopenia after radiotherapy products; anti-inflammatory topical blood circulation enhancers; non-steroidal anti-inflammatory ophthalmic solutions; and proton pump inhibitors. In addition, it provides consumer healthcare products, such as nutritional health drugs, remedies for gastrointestinal diseases, western herbal medicines, cold remedies, ophthalmic solutions, anti-inflammatory/analgesics, hemorroidal remedies, dermal remedies, quasi-drugs/cosmetics, nutrient tonics, soft drinks/health foods, and food for specified health uses. The company was formerly known as Zeria Yakusho Kenkyusho Co., Ltd. and changed its name to Zeria Pharmaceutical Co., Ltd. in May 1970. Zeria Pharmaceutical Co., Ltd. was incorporated in 1955 and is headquartered in Tokyo, Japan.

Employees
1777
Market
Japan

Compare 4559 to Peers and Sector

Metrics to compare
4559
Peers
Sector
Relationship
P/E Ratio
11.6x12.0x−0.6x
PEG Ratio
1.090.020.00
Price/Book
1.1x1.0x2.6x
Price / LTM Sales
1.2x1.5x3.1x
Upside (Analyst Target)
43.4%13.0%53.0%
Fair Value Upside
Unlock24.2%8.0%Unlock

Analyst Ratings

1 Buy
0 Hold
0 Sell
Ratings:
1 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 3,170.0

(+43.37% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 190.47
Dividend Yield
2.08%
Industry Median 2.28%
Annualised payout
46
Paid unevenly
5-Years Growth
+5.29%
Growth Streak

Earnings

Latest Release
Nov 06, 2024
EPS / Forecast
41.94 / --
Revenue / Forecast
20.97B / 18.295B
EPS Revisions
Last 90 days

FAQ

What Is the Zeria Pharmaceutical (4559) Stock Price Today?

The Zeria Pharmaceutical stock price today is 2,211.00

What Stock Exchange Does Zeria Pharmaceutical Trade On?

Zeria Pharmaceutical is listed and trades on the Tokyo stock exchange.

What Is the Stock Symbol for Zeria Pharmaceutical?

The stock symbol for Zeria Pharmaceutical is "4559."

Does Zeria Pharmaceutical Pay Dividends? What’s The Current Dividend Yield?

The Zeria Pharmaceutical dividend yield is 2.08%.

What Is the Zeria Pharmaceutical Market Cap?

As of today, Zeria Pharmaceutical market cap is 97.46B.

What is Zeria Pharmaceutical Earnings Per Share?

The Zeria Pharmaceutical EPS is 190.47.

What Is the Next Zeria Pharmaceutical Earnings Date?

Zeria Pharmaceutical will release its next earnings report on 04 Feb 2025.

From a Technical Analysis Perspective, Is 4559 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.